Search alternatives:
significant increases » significant increase (Expand Search), significantly increased (Expand Search), significant decrease (Expand Search)
point decrease » point increase (Expand Search)
increases risk » increased risk (Expand Search), increased risks (Expand Search), increasing risk (Expand Search)
onto decrease » nn decrease (Expand Search)
Showing 41 - 60 results of 47,237 for search '(( significantly ((onto decrease) OR (point decrease)) ) OR ( significant increases risk ))', query time: 0.74s Refine Results
  1. 41
    Switching patterns of ICS/LABA.

    Switching patterns of ICS/LABA. by Rieko Kondo (10010647)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  2. 42
    Factors associated with exacerbations.

    Factors associated with exacerbations. by Rieko Kondo (10010647)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  3. 43
    Definition of each exacerbation.

    Definition of each exacerbation. by Rieko Kondo (10010647)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  4. 44
    Definitions of treatment step classification.

    Definitions of treatment step classification. by Rieko Kondo (10010647)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  5. 45
    Sensitivity analyses of breakthrough exacerbations.

    Sensitivity analyses of breakthrough exacerbations. by Rieko Kondo (10010647)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  6. 46
    Baseline characteristics of patients.

    Baseline characteristics of patients. by Rieko Kondo (10010647)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  7. 47
    Data for primary and sensitivity analysis.

    Data for primary and sensitivity analysis. by Rieko Kondo (10010647)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  8. 48
    Study design.

    Study design. by Rieko Kondo (10010647)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  9. 49
    Odds ratios for each case period compared with the control period.

    Odds ratios for each case period compared with the control period. by Rieko Kondo (10010647)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  10. 50
    Sensitivity analysis of the group who had an exacerbation before the index date.

    Sensitivity analysis of the group who had an exacerbation before the index date. by Rieko Kondo (10010647)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  11. 51
    Initial post-switch visits and SABA prescriptions in each period.

    Initial post-switch visits and SABA prescriptions in each period. by Rieko Kondo (10010647)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  12. 52
    Flow of eligible patients.

    Flow of eligible patients. by Rieko Kondo (10010647)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  13. 53
    ICS/LABA before and after switch.

    ICS/LABA before and after switch. by Rieko Kondo (10010647)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  14. 54
    Diseases excluded from the analysis.

    Diseases excluded from the analysis. by Rieko Kondo (10010647)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  15. 55
    Join-point regression analysis of the statistically significant linear increase in use of antidepressants during the observed time period.

    Join-point regression analysis of the statistically significant linear increase in use of antidepressants during the observed time period. by Jelena Filimonovic (22305307)

    Published 2025
    Save to List
    Saved in:
  16. 56
    Cephalometric measurement points.

    Cephalometric measurement points. by Lijuan Liu (136685)

    Published 2025
    Save to List
    Saved in:
  17. 57
    Join-point regression analysis of the statistically significant linear increase in use of antidementia and antipsychotics during the observed time period.

    Join-point regression analysis of the statistically significant linear increase in use of antidementia and antipsychotics during the observed time period. by Jelena Filimonovic (22305307)

    Published 2025
    Save to List
    Saved in:
  18. 58
    Significant mutations in RAD52, BRCA2, BRCA1 and PALB2.

    Significant mutations in RAD52, BRCA2, BRCA1 and PALB2. by Abdulaziz B. Hamid (13804692)

    Published 2022
    Save to List
    Saved in:
  19. 59
    Transepithelial resistance of NHBE decreases significantly after PAA exposure.

    Transepithelial resistance of NHBE decreases significantly after PAA exposure. by Ellie S. Burns (21246537)

    Published 2025
    Save to List
    Saved in:
  20. 60
    Proportion of individuals’ general benefits scores that increased, decreased, or remained unchanged between time points.

    Proportion of individuals’ general benefits scores that increased, decreased, or remained unchanged between time points. by Jessie B. Moore (12578140)

    Published 2023
    Save to List
    Saved in:

Search Tools: